Zobrazeno 1 - 8
of 8
pro vyhledávání: '"RON PREBLICK"'
Publikováno v:
PharmacoEconomics Open
Background\ud \ud A range of treatments for patients with severe hemophilia A (HA) have been developed over the last decade, allowing for reduced frequency of administration and improved outcomes (joint health and breakthrough bleeding rates). While
Publikováno v:
Diabetes, Obesity & Metabolism
AIMS To evaluate the clinical and patient-reported outcomes and healthcare utilization and costs associated with patient-reported hypoglycaemia in US adults with type 2 diabetes (T2D) treated with basal insulin. MATERIALS AND METHODS This was an obse
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 23:532-541
Introduction: Venous thromboembolism (VTE) represents a major clinical and economic burden. The American College of Chest Physicians (ACCP) Guideline 9th Edition on the treatment of VTE recommends a minimum duration of anticoagulation (AC) therapy de
Autor:
Vijay N. Joish, Sachin A. Paranjape, Fang L. Zhou, Sumit Verma, Steven V. Edelman, Michael J. Davies, Ron Preblick
Publikováno v:
Diabetes. 68
Around 75% of adults with T1D do not achieve glycemic control, putting them at risk of macrovascular complications. This observational study evaluated prevalence of CVD and cardiovascular risk factors (CVRF) in T1D and the economic impact on U.S. pay
Autor:
SEAN D. SULLIVAN, TIMOTHY S. BAILEY, RONAN ROUSSEL, FANG L. ZHOU, ZSOLT BOSNYAK, RON PREBLICK, JUKKA WESTERBACKA, RISHAB GUPTA, LAWRENCE BLONDE
Publikováno v:
Diabetes. 67
DELIVER D+ compared outcomes of patients with T2D switching from Gla-100/IDet to Gla-300 or IDeg. Results from 5 subgroups are reported (overall results in separate abstract). Electronic medical records (Predictive Health Intelligence Environment dat
Autor:
Sean D. Sullivan, Timothy S. Bailey, Lawrence Blonde, Rishab Gupta, Jukka Westerbacka, Fang L. Zhou, Ronan Roussel, Ron Preblick, Zsolt Bosnyak
Publikováno v:
Diabetes. 67
This retrospective, observational study compared clinical outcomes of adults with T2D switching from Gla-100/IDet to Gla-300 or IDeg. Electronic medical records (Predictive Health Intelligence Environment database) (3/1/15-1/31/17) were analyzed. Swi
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 8
Background: Renal impairment could be a risk factor for venous thromboembolism (VTE) recurrence and anticoagulation related bleeding in VTE patients. The objective of this study was to assess the effect of renal impairment on the risk of VTE recurren
Autor:
Mary L. Wagner, Ron Preblick
Publikováno v:
Archives of Neurology. 51:748-749
We commend Isojarvi et al 1 for their article, "Serum Lipid Levels During Carbamazepine Medication: A Prospective Study." This study should greatly contribute to the medical literature, but we are concerned that some of the conclusions are misleading